Technical Analysis for ACHV - Achieve Life Sciences, Inc.
Grade | Last Price | % Change | Price Change |
---|---|---|---|
C | 10.2 | -2.30% | -0.24 |
ACHV closed down 8.82 percent on Thursday, March 4, 2021, on 49 percent of normal volume. The stock fell below its 50 day moving average, damaging its intermediate-term outlook by crossing under that important trendline. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
Earnings due: Mar 11
*** please verify all earnings dates ***ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Strong | Up | Down | Down |
Historical ACHV trend table... |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Fell Below 50 DMA | Bearish | -4.31% | |
180 Bearish Setup | Bearish Swing Setup | -4.31% | |
Lower Bollinger Band Walk | Weakness | -4.31% | |
Wide Bands | Range Expansion | -4.31% | |
Lower Bollinger Band Touch | Weakness | -4.31% | |
Oversold Stochastic | Weakness | -4.31% | |
MACD Bearish Centerline Cross | Bearish | -12.75% | |
50 DMA Support | Bullish | -12.75% | |
Hammer Candlestick | Bullish | -12.75% | |
Wide Bands | Range Expansion | -12.75% |
Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App
Alert | Time | |
---|---|---|
200 DMA Support | about 2 hours ago | |
Fell Below 200 DMA | about 2 hours ago | |
Down 10% | about 2 hours ago | |
Down 1 ATR | about 2 hours ago | |
60 Minute Opening Range Breakdown | about 3 hours ago |
Get a Trading Assistant
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 03/11/2021
Achieve Life Sciences, Inc., a biopharmaceutical company, develops and commercializes therapies that address treatment resistance in cancer patients. It is developing Apatorsen to block the production of heat shock protein 27, a cell-survival protein expressed in various types of cancers, including bladder, prostate, breast, pancreatic, and non-small cell lung cancer. The company is headquartered in Bothell, Washington.
Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Cancer Cancers Breast Cancer Prostate Cancer Treatment Of Breast Cancer Small Cell Lung Cancer Non Small Cell Lung Cancer Oncolytics Biotech Apatorsen Clusterin
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Cancer Cancers Breast Cancer Prostate Cancer Treatment Of Breast Cancer Small Cell Lung Cancer Non Small Cell Lung Cancer Oncolytics Biotech Apatorsen Clusterin
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 18.26 |
52 Week Low | 4.514 |
Average Volume | 342,465 |
200-Day Moving Average | 9.41 |
50-Day Moving Average | 11.26 |
20-Day Moving Average | 13.34 |
10-Day Moving Average | 12.12 |
Average True Range | 1.14 |
ADX | 34.16 |
+DI | 15.93 |
-DI | 31.53 |
Chandelier Exit (Long, 3 ATRs ) | 12.68 |
Chandelier Exit (Short, 3 ATRs ) | 13.57 |
Upper Bollinger Band | 16.38 |
Lower Bollinger Band | 10.30 |
Percent B (%b) | 0.02 |
BandWidth | 45.57 |
MACD Line | -0.20 |
MACD Signal Line | 0.33 |
MACD Histogram | -0.5278 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 12.42 | ||||
Resistance 3 (R3) | 12.54 | 12.01 | 12.09 | ||
Resistance 2 (R2) | 12.01 | 11.50 | 11.94 | 11.98 | |
Resistance 1 (R1) | 11.22 | 11.19 | 10.96 | 11.10 | 11.87 |
Pivot Point | 10.69 | 10.69 | 10.55 | 10.63 | 10.69 |
Support 1 (S1) | 9.90 | 10.18 | 9.64 | 9.78 | 9.01 |
Support 2 (S2) | 9.37 | 9.87 | 9.31 | 8.90 | |
Support 3 (S3) | 8.58 | 9.37 | 8.79 | ||
Support 4 (S4) | 8.46 |